BillionToOne to Report Q1 2026 Earnings on May 6

The molecular diagnostics company will host a conference call to discuss its financial results.

Apr. 15, 2026 at 12:41pm

Got story updates? Submit your updates here. ›

A highly detailed, cinematic close-up photograph of complex medical diagnostic machinery, conveying a sense of technological sophistication and innovation.BillionToOne's cutting-edge molecular diagnostics technology powers the next generation of personalized healthcare solutions.Menlo Park Today

BillionToOne, Inc., a next-generation molecular diagnostics company, announced that it will release its financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, May 6, 2026. The company will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.

Why it matters

As a leading molecular diagnostics company, BillionToOne's quarterly earnings report will provide insights into the performance and growth of its innovative DNA testing technologies. The company's patented Quantitative Counting Templates platform is a key differentiator in the diagnostics market.

The details

BillionToOne, headquartered in Menlo Park, California, plans to release its Q1 2026 financial results after the market close on May 6, 2026. The company will host a conference call at 1:30pm PT / 4:30pm ET the same day for analysts and investors to discuss the results.

  • BillionToOne will release its Q1 2026 financial results after the market close on May 6, 2026.
  • The company will host a conference call at 1:30pm Pacific Time / 4:30pm Eastern Time on May 6, 2026 to discuss the results.

The players

BillionToOne, Inc.

A next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level.

Got photos? Submit your photos here. ›

What’s next

Analysts planning to participate in the conference call should register in advance before the 1:30pm Pacific Time / 4:30pm Eastern Time start.

The takeaway

BillionToOne's upcoming earnings report will provide valuable insights into the performance and growth of its innovative molecular diagnostics technologies, which are poised to play a key role in the future of healthcare.